2009 Lung Cancer Research Foundation Annual Grant Program
Rachel Linger, MD, PhD
University of Colorado Denver
Research Project:
Novel Biolocially Targeted Therapy for the Treatment of Lung Cancer
Summary:
This proposal extends the first phase of LCRF supported research by Dr. Linger into practical applications of treatment opportunities. It capitalizes on her outstanding productive work on a new target (Axl receptor tyrosine kinase) for the therapy of lung cancer and is on the cutting edge of potentially fundamental new advances in the disease.